MDVN

Medivation, Inc. News Headlines

$76.72
*  
0.41
0.54%
Get MDVN Alerts
*Delayed - data as of Jul. 29, 2014 10:33 ET  -  Find a broker to begin trading MDVN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MDVN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

First Week of MDVN March 2015 Options Trading
7/22/2014 12:18:39 PM - BNK Invest

Astellas Up on Pipeline Update, Oncology in Focus (revised) - Analyst Blog
7/21/2014 4:07:46 PM - Zacks.com

Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion
7/21/2014 2:06:00 PM - Seeking Alpha

Astellas Up on Pipeline Update, Oncology in Focus - Analyst Blog
7/16/2014 3:03:00 PM - Zacks.com

Medivation Set To Go Higher As Prostate Cancer Drug Xtandi Quickly Approaches Blockbuster Status
7/10/2014 2:03:00 PM - Seeking Alpha

What Does Dendreon Need To Succeed?
7/7/2014 10:48:00 AM - Seeking Alpha

Two Cancer Stocks Take Shots On Goal: Echo He
6/19/2014 11:00:00 AM - Seeking Alpha

Moving Average Crossover Alert: Medivation (MDVN) - Tale of the Tape
6/18/2014 9:39:57 AM - Zacks.com

The Spectranetics (SPNC) Crumbles: Stock Falls by 8.1% - Tale of the Tape
5/29/2014 8:55:00 AM - Zacks.com

Medivation Larger Than S&P 500 Component Zions Bancorporation
5/19/2014 4:37:23 PM - BNK Invest

Biotech Stock Roundup: Medivation Gains on Xtandi Strength, Amgen Scores in Late-Stage Study - Analyst Blog
5/14/2014 9:46:00 AM - Zacks.com

Strength Seen in Medivation (MDVN): Stock Up 8.5% - Tale of the Tape
5/12/2014 9:25:00 AM - Zacks.com

Friday's ETF Movers: XBI, GDXJ
5/9/2014 2:24:32 PM - BNK Invest

Medivation Q1 Loss Wider Than Expected - Analyst Blog
5/9/2014 10:10:00 AM - Zacks.com

Medivation Q1 Loss Narrows - Quick Facts
5/8/2014 4:37:00 PM - RTT News

Will Regeneron (REGN) Disappoint in Q1 Earnings? - Analyst Blog
5/7/2014 5:20:01 PM - Zacks.com

Why Earnings Season Could Be Great for Medivation (MDVN) - Tale of the Tape
5/6/2014 8:30:01 AM - Zacks.com

Astellas, Medivation Granted Priority Review From FDA For XTANDI Capsules
5/6/2014 7:57:00 AM - RTT News

Medivation Signs Deal with OncoFusion Therapeutics - Analyst Blog
4/24/2014 6:24:01 PM - Zacks.com

Strong Rebound for Healthcare Stocks Tuesday; Medivation, UCLA In Legal Fight Over Royalty Payments
4/15/2014 3:51:58 PM - MT Newswires

Sector Update: Healthcare
4/15/2014 3:51:10 PM - MT Newswires

Bayer Initiates Xofigo Combination Study - Analyst Blog
4/3/2014 5:30:01 PM - Zacks.com

Medivation Breaks Below 200-Day Moving Average - Notable for MDVN
3/27/2014 1:15:11 PM - BNK Invest

Japan Approves Medivation/Astellas' Xtandi - Analyst Blog
3/25/2014 1:50:01 PM - Zacks.com

Medivation-Astellas Seek Xtandi Label Expansion - Analyst Blog
3/19/2014 4:20:01 PM - Zacks.com